CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study

Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review

(2012) D. Dove et al.   PEDIATRICS

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

(2012) S C Sim et al.   PHARMACOGENOMICS JOURNAL

The Pharmacoepidemiology of Antipsychotic Medications for Canadian Children and Adolescents: 2005–2009

(2011) Tamara Pringsheim et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Risperidone in Schizophrenia: Is There a Role for Therapeutic Drug Monitoring?

(2011) Katherine Seto et al.   THERAPEUTIC DRUG MONITORING

Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes

(2010) S Mas et al.   PHARMACOGENOMICS JOURNAL

Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia

(2009) Tatsuhiko Yagihashi et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Effects of CYP2D6 and CYP3A5 Genotypes on the Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Korean Schizophrenic Patients

(2009) Rhee-Hun Kang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

CYP2D6genotyping for psychiatric patients treated with risperidone: considerations for cost–effectiveness studies

(2009) Cristina Rodríguez-Antona et al.   PHARMACOGENOMICS

Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions

(2009) C T Correia et al.   PHARMACOGENOMICS JOURNAL

Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities

(2008) José de Leon et al.   CLINICS IN LABORATORY MEDICINE

Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders

(2008) D. S. Mandell et al.   PEDIATRICS